143 related articles for article (PubMed ID: 23161221)
1. Enhanced suppression of proliferation and migration in highly-metastatic lung cancer cells by combination of valproic acid and coumarin-3-carboxylic acid and its molecular mechanisms of action.
Liu X; Chen L; Sun F; Zhang G
Cytotechnology; 2013 Aug; 65(4):597-608. PubMed ID: 23161221
[TBL] [Abstract][Full Text] [Related]
2. Suppression of proliferation and migration in highly-metastatic lung cancer cells as well as tumor growth by a new synthesized compound TBrC and its molecular mechanisms of action.
Ji D; Wang Y; Zhang H; Chen L; Liu X; Sun F; Liu K; Yao J; Zhang G
Cytotechnology; 2014 Dec; 66(6):899-911. PubMed ID: 24132498
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines.
Shirsath N; Rathos M; Chaudhari U; Sivaramakrishnan H; Joshi K
Lung Cancer; 2013 Nov; 82(2):214-21. PubMed ID: 24051085
[TBL] [Abstract][Full Text] [Related]
4. Curcumin p38-dependently enhances the anticancer activity of valproic acid in human leukemia cells.
Chen J; Wang G; Wang L; Kang J; Wang J
Eur J Pharm Sci; 2010 Oct; 41(2):210-8. PubMed ID: 20600877
[TBL] [Abstract][Full Text] [Related]
5. Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action.
Jiang Y; Zhang Y; Luan J; Duan H; Zhang F; Yagasaki K; Zhang G
Cytotechnology; 2010 Dec; 62(6):573-83. PubMed ID: 20963488
[TBL] [Abstract][Full Text] [Related]
6. Theanine from tea and its semi-synthetic derivative TBrC suppress human cervical cancer growth and migration by inhibiting EGFR/Met-Akt/NF-κB signaling.
Liu J; Sun Y; Zhang H; Ji D; Wu F; Tian H; Liu K; Zhang Y; Wu B; Zhang G
Eur J Pharmacol; 2016 Nov; 791():297-307. PubMed ID: 27612630
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide prevents valproic acid-induced apoptosis via activation of nuclear factor-κB and inhibition of p53 activation.
Tsolmongyn B; Koide N; Odkhuu E; Haque A; Naiki Y; Komatsu T; Yoshida T; Yokochi T
Cell Immunol; 2013 Apr; 282(2):100-5. PubMed ID: 23770718
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of Nrf2 by the combination of TRAIL and Valproic acid induces apoptotic cell death of TRAIL-resistant papillary thyroid cancer cells via suppression of Bcl-xL.
Cha HY; Lee BS; Chang JW; Park JK; Han JH; Kim YS; Shin YS; Byeon HK; Kim CH
Cancer Lett; 2016 Mar; 372(1):65-74. PubMed ID: 26721202
[TBL] [Abstract][Full Text] [Related]
9. The G1 phase arrest and apoptosis by intrinsic pathway induced by valproic acid inhibit proliferation of BGC-823 gastric carcinoma cells.
Zhao X; Yang W; Shi C; Ma W; Liu J; Wang Y; Jiang G
Tumour Biol; 2011 Apr; 32(2):335-46. PubMed ID: 21113745
[TBL] [Abstract][Full Text] [Related]
10. Valproic acid, an anti-epileptic drug and a histone deacetylase inhibitor, in combination with proteasome inhibitors exerts antiproliferative, pro-apoptotic and chemosensitizing effects in human colorectal cancer cells: underlying molecular mechanisms.
Abaza MS; Bahman AM; Al-Attiyah RJ
Int J Mol Med; 2014 Aug; 34(2):513-32. PubMed ID: 24899129
[TBL] [Abstract][Full Text] [Related]
11. Effects of valproic acid on the cell cycle and apoptosis through acetylation of histone and tubulin in a scirrhous gastric cancer cell line.
Yagi Y; Fushida S; Harada S; Kinoshita J; Makino I; Oyama K; Tajima H; Fujita H; Takamura H; Ninomiya I; Fujimura T; Ohta T; Yashiro M; Hirakawa K
J Exp Clin Cancer Res; 2010 Nov; 29(1):149. PubMed ID: 21080974
[TBL] [Abstract][Full Text] [Related]
12. Combination of Arsenic Trioxide and Valproic Acid Efficiently Inhibits Growth of Lung Cancer Cells via G2/M-Phase Arrest and Apoptotic Cell Death.
Park HK; Han BR; Park WH
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290325
[TBL] [Abstract][Full Text] [Related]
13. Synergistic antitumor activity of oridonin and valproic acid on HL-60 leukemia cells.
Li W; Ma L
J Cell Biochem; 2019 Apr; 120(4):5620-5627. PubMed ID: 30320906
[TBL] [Abstract][Full Text] [Related]
14. A novel combination of oridonin and valproic acid in enhancement of apoptosis induction of HL-60 leukemia cells.
Shi M; Ren X; Wang X; Wang H; Liu G; Yuan X; Zheng S; Yu L; Pan S; Song G; Guo Q; Li L; Zhang X; Zhang Z; Ding H; Jiang G
Int J Oncol; 2016 Feb; 48(2):734-46. PubMed ID: 26676928
[TBL] [Abstract][Full Text] [Related]
15. [Experimental study on the mechanism of the apoptosis of leukemic cells induced by valproic acid].
Xue HM; Li WY; Guo HX; Xia Y; Chen Q; Liu Y
Zhonghua Er Ke Za Zhi; 2005 Dec; 43(12):894-8. PubMed ID: 16412349
[TBL] [Abstract][Full Text] [Related]
16. The role and possible molecular mechanism of valproic acid in the growth of MCF-7 breast cancer cells.
Ma XJ; Wang YS; Gu WP; Zhao X
Croat Med J; 2017 Oct; 58(5):349-357. PubMed ID: 29094813
[TBL] [Abstract][Full Text] [Related]
17. Combination of sorafenib and Valproic acid synergistically induces cell apoptosis and inhibits hepatocellular carcinoma growth via down-regulating Notch3 and pAkt.
Zhu W; Liang Q; Yang X; Yu Y; Shen X; Sun G
Am J Cancer Res; 2017; 7(12):2503-2514. PubMed ID: 29312803
[TBL] [Abstract][Full Text] [Related]
18. Prevention of hypoxia-induced neuronal apoptosis through histone deacetylase inhibition.
Li Y; Yuan Z; Liu B; Sailhamer EA; Shults C; Velmahos GC; Demoya M; Alam HB
J Trauma; 2008 Apr; 64(4):863-70; discussion 870-1. PubMed ID: 18404049
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid inhibits proliferation of HER2-expressing breast cancer cells by inducing cell cycle arrest and apoptosis through Hsp70 acetylation.
Mawatari T; Ninomiya I; Inokuchi M; Harada S; Hayashi H; Oyama K; Makino I; Nakagawara H; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
Int J Oncol; 2015 Dec; 47(6):2073-81. PubMed ID: 26497673
[TBL] [Abstract][Full Text] [Related]
20. Matrine suppresses breast cancer cell proliferation and invasion via VEGF-Akt-NF-kappaB signaling.
Yu P; Liu Q; Liu K; Yagasaki K; Wu E; Zhang G
Cytotechnology; 2009 Apr; 59(3):219-29. PubMed ID: 19760125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
